Our investigation, which demonstrates the association between impaired removal of TOP1cc and defective NF‐κB activation and WRN deficiency, explains enhanced survival of colorectal cancer patients with WRN deficiency in response TOP1 inhibitor treatment (Agrelo et al., 2006). This evidence concerns the gene TOP1 and colorectal cancer.